News
The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.
This prescription form is for single-use veterinary prescriptions, unless otherwise certified.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results